T1	Condition 11 32	organic brain disease
T2	Observation 0 10	History of
R1	Has_temporal Arg1:T1 Arg2:T2	
T3	Qualifier 34 40	DSM-IV
T4	Condition 54 61;75 85	Alcohol Dependence
T5	Condition 65 85	Substance Dependence
*	OR T5 T4
T6	Scope 54 85	Alcohol or Substance Dependence
R2	Has_qualifier Arg1:T6 Arg2:T3	
T7	Temporal 86 112	within the last six months
R3	Has_temporal Arg1:T6 Arg2:T7	
T8	Drug 121 129	nicotine
T9	Negation 114 120	except
R4	Has_negation Arg1:T8 Arg2:T9	
R5	AND Arg1:T6 Arg2:T8	
T10	Qualifier 134 139	DSM-5
T11	Condition 153 175	Substance Use Disorder
R6	Has_qualifier Arg1:T11 Arg2:T10	
T12	Temporal 176 198	in the last six months
T13	Drug 207 215	nicotine
T14	Negation 200 206	except
R7	Has_negation Arg1:T13 Arg2:T14	
R8	Has_temporal Arg1:T11 Arg2:T12	
R9	Has_negation Arg1:T11 Arg2:T14	
T15	Qualifier 218 224	DSM-IV
T16	Condition 238 245;259 264	Alcohol Abuse
T17	Condition 249 264	Substance Abuse
*	OR T17 T16
T18	Scope 238 264	Alcohol or Substance Abuse
R10	Has_qualifier Arg1:T18 Arg2:T15	
T19	Temporal 265 290	within the last one month
T20	Drug 299 307	nicotine
T21	Negation 292 298	except
R11	Has_negation Arg1:T20 Arg2:T21	
R12	Has_temporal Arg1:T18 Arg2:T19	
R13	AND Arg1:T18 Arg2:T20	
T22	Qualifier 312 317	DSM-5
T23	Condition 331 353	Substance Use Disorder
T24	Temporal 354 376	in the last six months
R14	Has_temporal Arg1:T23 Arg2:T24	
R15	Has_qualifier Arg1:T23 Arg2:T22	
T25	Drug 385 393	nicotine
T26	Negation 378 384	except
R16	Has_negation Arg1:T25 Arg2:T26	
R17	AND Arg1:T23 Arg2:T25	
T27	Scope 312 394	DSM-5 diagnosis of Substance Use Disorder in the last six months (except nicotine)
*	OR T18 T27
T28	Condition 396 405	Pregnancy
T29	Condition 409 418	lactation
*	OR T28 T29
T30	Condition 427 444	liver dysfunction
T31	Qualifier 420 426	Severe
R18	Has_qualifier Arg1:T30 Arg2:T31	
T32	Measurement 446 449	LFT
T33	Value 450 474	3X upper limit of normal
R19	Has_value Arg1:T32 Arg2:T33	
T34	Scope 446 474	LFT 3X upper limit of normal
R20	Has_scope Arg1:T30 Arg2:T34	
T35	Condition 492 508	hypersensitivity
T36	Drug 512 525	tetracyclines
R21	AND Arg1:T35 Arg2:T36	
T37	Temporal 477 485	Previous
R22	Has_temporal Arg1:T35 Arg2:T37	
T38	Temporal 527 534	Current
T39	Procedure 535 544	treatment
T40	Drug 550 562	tetracycline
T41	Drug 550 562;566 576	tetracycline derivative
*	OR T40 T41
R23	Has_temporal Arg1:T39 Arg2:T38	
T42	Scope 550 576	tetracycline or derivative
R24	Has_scope Arg1:T39 Arg2:T42	
T43	Drug 593 612	oral contraceptives
T44	Procedure 578 587	Treatment
R25	AND Arg1:T44 Arg2:T43	
T45	Observation 638 651	birth control
T46	Qualifier 623 634	second form
R26	Has_qualifier Arg1:T45 Arg2:T46	
T47	Negation 614 620	unless
R27	Has_negation Arg1:T45 Arg2:T47	
R28	Has_context Arg1:T44 Arg2:T45	
T48	Drug 692 706	cholestyramine
T49	Drug 710 720	colestipol
*	OR T48 T49
T50	Procedure 677 686	Treatment
T51	Scope 692 720	cholestyramine or colestipol
R29	Has_scope Arg1:T50 Arg2:T51	
T52	Procedure 722 731	Treatment
T53	Drug 737 757	Urinary alkalinizers
T54	Drug 765 779	sodium lactate
T55	Drug 781 798	potassium citrate
*	OR T54 T55
T56	Scope 765 798	sodium lactate, potassium citrate
R30	Subsumes Arg1:T53 Arg2:T56	
R31	AND Arg1:T52 Arg2:T53	
T57	Drug 816 824	warfarin
T58	Procedure 801 810	Treatment
R32	AND Arg1:T58 Arg2:T57	
T59	Drug 841 850	bupropion
T60	Drug 852 863	varenicline
T61	Drug 868 897	nicotine replacement products
*	OR T60 T61 T59
T62	Scope 841 897	bupropion, varenicline, or nicotine replacement products
T63	Temporal 898 935	in the month prior to study inclusion
T64	Reference_point 920 935	study inclusion
R33	Has_index Arg1:T63 Arg2:T64	
T65	Procedure 826 835	Treatment
R34	Has_scope Arg1:T65 Arg2:T62	
R35	Has_temporal Arg1:T62 Arg2:T63	
T66	Multiplier 937 957	Less than two months
T67	Procedure 958 967	treatment
T68	Drug 971 993	adjunctive medications
T69	Multiplier 998 1017	less than one month
T70	Multiplier 1021 1030	same dose
T71	Drug 1032 1045	beta blockers
T72	Drug 1047 1062	antidepressants
T73	Drug 1064 1080	mood stabilizers
R36	AND Arg1:T67 Arg2:T68	
R37	Has_multiplier Arg1:T67 Arg2:T66	
R38	Has_multiplier Arg1:T70 Arg2:T69	
R39	Has_multiplier Arg1:T67 Arg2:T70	
*	OR T71 T72 T73 T74
T74	Drug 1082 1105	antianxiety medications
T75	Scope 1032 1105	beta blockers, antidepressants, mood stabilizers, antianxiety medications
R40	Subsumes Arg1:T68 Arg2:T75	
T76	Condition 1108 1125	Medical condition
T77	Qualifier 1155 1230	would significantly increase the risk associated with the proposed protocol
R41	Has_qualifier Arg1:T76 Arg2:T77	
T78	Condition 1244 1255	head injury
T79	Condition 1257 1265	seizures
T80	Condition 1270 1276	stroke
*	OR T80 T79 T78
T81	Observation 1233 1240	History
T82	Scope 1244 1276	head injury, seizures, or stroke
R42	Has_temporal Arg1:T82 Arg2:T81	
T83	Measurement 1287 1310	urine toxicology screen
T84	Qualifier 1315 1348	substances of non-therapeutic use
T85	Value 1278 1286	Positive
R43	Has_qualifier Arg1:T83 Arg2:T84	
R44	Has_value Arg1:T83 Arg2:T85	
T86	Temporal 1349 1377	prior to craving assessments
T87	Reference_point 1358 1377	craving assessments
R45	Has_index Arg1:T86 Arg2:T87	
R46	Has_temporal Arg1:T83 Arg2:T86	
